id
name
processing priority
4
site type
0 (generic, awaiting analysis)
review version
11
html import
20 (imported)
first seen date
2023-12-21 15:00:16
expired found date
-
created at
2024-06-06 05:22:57
updated at
2025-12-29 01:32:35
length
10
crc
36320
tld
2211
nm parts
0
nm random digits
0
nm rare letters
0
is subdomain of id
-
previous id
0
replaced with id
0
related id
-
dns primary id
dns alternative id
0
lifecycle status
0 (unclassified, or currently active)
deleted subdomains
0
page imported products
0
page imported random
0
page imported parking
0
count skipped due to recent timeouts on the same server IP
0
count content received but rejected due to 11-799
0
count dns errors
0
count cert errors
0
count timeouts
0
count http 429
0
count http 404
0
count http 403
0
count http 5xx
0
next operation date
2025-05-01 10:47:11
server bits
—
server ip
-
mp import status
20
mp rejected date
-
mp saved date
-
mp size orig
83838
mp size raw text
10542
mp inner links count
1
mp inner links status
20 (imported)
title
GAZYVA® (obinutuzumab) Treatment, Indications, Dosing & Safety
description
Learn about GAZYVA® (obinutuzumab) for first-line, R/R follicular lymphoma & first-line CLL. See important safety including Boxed Warnings for more information.
site name
gazyva
author
updated
2025-12-16 16:17:49
raw text
GAZYVA® (obinutuzumab) Treatment, Indications, Dosing & Safety Prescribing Information Safety Prescribing Information Prescribing Information Safety Safety MENU Prescribing Information Safety GAZYVA ® (obinutuzumab) For Patients & Caregivers Previously Untreated Follicular Lymphoma Relapsed or Refractory Follicular Lymphoma Previously Untreated Chronic Lymphocytic Leukemia GAZYVA ® (obinutuzumab) For US Healthcare Professionals Previously Untreated Follicular Lymphoma Relapsed or Refractory Follicular Lymphoma Previously Untreated Chronic Lymphocytic Leukemia Important Safety Information and Indications Back to Top Indications GAZYVA ® (obinutuzumab) is a prescription medicine used in combination with chemotherapy, followed by GAZYVA alone in those who responded, to treat stage II bulky, III, ...
redirect type
0 (-)
block type
0 (no issues)
detected language
1 (English)
category id
index version
2025110801
spam phrases
0
text nonlatin
0
text cyrillic
0
text characters
8148
text words
1536
text unique words
452
text lines
105
text sentences
80
text paragraphs
24
text words per sentence
19
text matched phrases
3
text matched dictionaries
6
links self subdomains
0
links other subdomains
0
links other domains
links spam adult
0
links spam random
0
links spam expired
0
links ext activities
0
links ext ecommerce
0
links ext finance
0
links ext crypto
0
links ext booking
0
links ext news
0
links ext leaks
0
links ext ugc
0
links ext klim
0
links ext generic
1
dol status
0
dol updated
2025-12-16 16:17:49
rss path
rss status
1 (priority 1 already searched, no matches found)
rss found date
-
rss size orig
0
rss items
0
rss spam phrases
0
rss detected language
0 (awaiting analysis)
inbefore feed id
-
inbefore status
0 (new)
sitemap path
sitemap status
30 (processing completed, results pushed to table crawler_sitemaps.ext_domain_sitemap_lists)
sitemap review version
2
sitemap urls count
65
sitemap urls adult
0
sitemap filtered products
0
sitemap filtered videos
0
sitemap found date
2024-01-09 02:50:56
sitemap process date
2025-05-06 10:43:55
sitemap first import date
-
sitemap last import date
-